The absolute lactate levels versus clearance for prognostication of post‐cardiotomy patients on veno‐arterial ECMO

Abstract Aims Veno‐arterial extracorporeal membrane oxygenation (VA‐ECMO) is a life‐saving procedure for supporting patients with cardiogenic shock after cardiac surgery. This work aimed to analyse the impact of changes in blood lactate levels on the survival of patients on post‐cardiotomy ECMO (PC‐...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohamed Laimoud, Patricia Machado, Michelle Gretchen Lo, Mary Jane Maghirang, Emad Hakami, Rehan Qureshi
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:ESC Heart Failure
Subjects:
Online Access:https://doi.org/10.1002/ehf2.14910
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846128385812594688
author Mohamed Laimoud
Patricia Machado
Michelle Gretchen Lo
Mary Jane Maghirang
Emad Hakami
Rehan Qureshi
author_facet Mohamed Laimoud
Patricia Machado
Michelle Gretchen Lo
Mary Jane Maghirang
Emad Hakami
Rehan Qureshi
author_sort Mohamed Laimoud
collection DOAJ
description Abstract Aims Veno‐arterial extracorporeal membrane oxygenation (VA‐ECMO) is a life‐saving procedure for supporting patients with cardiogenic shock after cardiac surgery. This work aimed to analyse the impact of changes in blood lactate levels on the survival of patients on post‐cardiotomy ECMO (PC‐ECMO) and whether lactate clearance (LC) performs better than absolute lactate levels. Methods and Results We retrospectively analysed the data of adult patients who received PC‐ECMO at our centre between 2016 and 2022. The primary outcome was the in‐hospital mortality rate. Arterial lactate levels were measured at ECMO initiation, peak and 12 and 24 h after VA‐ECMO support. LC was calculated at 12 and 24 h. Out of 2368 patients who received cardiac surgeries, 152 (median age, 48 years; 57.9% of them were men) received PC‐ECMO. Of them, 48 (31.6%) survived and were discharged, while 104 (68.4%) died during the index hospitalization. Non‐survivors had higher frequencies of atrial fibrillation (41.35% vs. 12.5%, P < 0.001), chronic kidney disease (26.9% vs. 6.3%, P = 0.004), prolonged cardiopulmonary bypass (237 vs. 192 min, P = 0.016) and aortic cross‐clamping times (160 vs. 124 min, P = 0.04) than survivors. Non‐survivors had a significantly higher median Sequential Organ Failure Assessment (SOFA) score at ECMO initiation (13.5 vs. 9, P < 0.001) and a lower median Survival After Veno‐arterial ECMO (SAVE) score (−3 vs. 3, P < 0.001) with higher SAVE classes (P < 0.001) than survivors. After 12 h of VA‐ECMO support, the blood lactate level was negatively correlated with LC in survivors (r = −0.755, P < 0.001) and non‐survivors (r = −0.601, P < 0.001). After 24 h, the same negative correlation was identified between survivors (r = −0.764, P < 0.001) and non‐survivors (r = −0.847, P < 0.001). Blood lactate levels measured at 12 h to determine hospital mortality [>8.2 mmol/L, area under the receiver operating characteristic curve (AUROC): 0.868] and 24 h (>2.6 mmol/L, AUROC: 0.896) had the best performance, followed by LC‐T12 (<21.94%, AUROC: 0.807), LC‐T24 (<40.3%, AUROC: 0.839) and peak blood lactate (>14.35 mmol/L, AUROC: 0.828). The initial pre‐ECMO blood lactate (>6.25 mmol/L, AUROC: 0.731) had an acceptable ability to discriminate mortality but was less than the following measurements and clearance. Kaplan–Meier curves demonstrated that LC of <21.94% at T12 h and <40.3% at T24 h was associated with decreased survival (log‐rank P < 0.001). Cox proportional hazards regression analysis for mortality revealed that LC of <21.94% at T12 h had an adjusted hazard ratio (HR) of 2.73 [95% confidence interval (CI): 1.64–5.762, P < 0.001] and LC of <40.3% at T24 h had an adjusted HR of 1.98 (95% CI: 1.46–4.173, P < 0.001). The predictors of hospital mortality after PC‐ECMO were the lactate level at 12 h [odds ratio (OR): 1.67, 95% CI: 1.121–2.181, P = 0.001], initial SOFA score (OR: 1.593, 95% CI: 1.15–2.73, P < 0.001), initial blood lactate (OR: 1.21, 95% CI: 1.016–1.721, P = 0.032) and atrial fibrillation (OR: 6.17, 95% CI: 2.37–57.214, P = 0.003). Bivariate models using lactate levels and clearance at the same points revealed that blood lactate levels performed better than the clearance percentage. Conclusions Serial measurements of arterial blood lactate and LC help in obtaining early prognostic guidance in adult patients supported by VA‐ECMO after cardiac surgery. Absolute lactate levels, compared with LC at the same time points, demonstrated better performance in differentiating mortality.
format Article
id doaj-art-430ec8ef5f994fd5989ceaff3bae04b7
institution Kabale University
issn 2055-5822
language English
publishDate 2024-12-01
publisher Wiley
record_format Article
series ESC Heart Failure
spelling doaj-art-430ec8ef5f994fd5989ceaff3bae04b72024-12-11T01:56:59ZengWileyESC Heart Failure2055-58222024-12-011163511352210.1002/ehf2.14910The absolute lactate levels versus clearance for prognostication of post‐cardiotomy patients on veno‐arterial ECMOMohamed Laimoud0Patricia Machado1Michelle Gretchen Lo2Mary Jane Maghirang3Emad Hakami4Rehan Qureshi5Department of Cardiovascular Critical Care King Faisal Specialist Hospital and Research Center Riyadh Saudi ArabiaDepartment of Cardiovascular Nursing King Faisal Specialist Hospital and Research Center Riyadh Saudi ArabiaDepartment of Cardiovascular Nursing King Faisal Specialist Hospital and Research Center Riyadh Saudi ArabiaDepartment of Cardiovascular Nursing King Faisal Specialist Hospital and Research Center Riyadh Saudi ArabiaDepartment of Cardiovascular Nursing King Faisal Specialist Hospital and Research Center Riyadh Saudi ArabiaDepartment of Cardiovascular Critical Care King Faisal Specialist Hospital and Research Center Riyadh Saudi ArabiaAbstract Aims Veno‐arterial extracorporeal membrane oxygenation (VA‐ECMO) is a life‐saving procedure for supporting patients with cardiogenic shock after cardiac surgery. This work aimed to analyse the impact of changes in blood lactate levels on the survival of patients on post‐cardiotomy ECMO (PC‐ECMO) and whether lactate clearance (LC) performs better than absolute lactate levels. Methods and Results We retrospectively analysed the data of adult patients who received PC‐ECMO at our centre between 2016 and 2022. The primary outcome was the in‐hospital mortality rate. Arterial lactate levels were measured at ECMO initiation, peak and 12 and 24 h after VA‐ECMO support. LC was calculated at 12 and 24 h. Out of 2368 patients who received cardiac surgeries, 152 (median age, 48 years; 57.9% of them were men) received PC‐ECMO. Of them, 48 (31.6%) survived and were discharged, while 104 (68.4%) died during the index hospitalization. Non‐survivors had higher frequencies of atrial fibrillation (41.35% vs. 12.5%, P < 0.001), chronic kidney disease (26.9% vs. 6.3%, P = 0.004), prolonged cardiopulmonary bypass (237 vs. 192 min, P = 0.016) and aortic cross‐clamping times (160 vs. 124 min, P = 0.04) than survivors. Non‐survivors had a significantly higher median Sequential Organ Failure Assessment (SOFA) score at ECMO initiation (13.5 vs. 9, P < 0.001) and a lower median Survival After Veno‐arterial ECMO (SAVE) score (−3 vs. 3, P < 0.001) with higher SAVE classes (P < 0.001) than survivors. After 12 h of VA‐ECMO support, the blood lactate level was negatively correlated with LC in survivors (r = −0.755, P < 0.001) and non‐survivors (r = −0.601, P < 0.001). After 24 h, the same negative correlation was identified between survivors (r = −0.764, P < 0.001) and non‐survivors (r = −0.847, P < 0.001). Blood lactate levels measured at 12 h to determine hospital mortality [>8.2 mmol/L, area under the receiver operating characteristic curve (AUROC): 0.868] and 24 h (>2.6 mmol/L, AUROC: 0.896) had the best performance, followed by LC‐T12 (<21.94%, AUROC: 0.807), LC‐T24 (<40.3%, AUROC: 0.839) and peak blood lactate (>14.35 mmol/L, AUROC: 0.828). The initial pre‐ECMO blood lactate (>6.25 mmol/L, AUROC: 0.731) had an acceptable ability to discriminate mortality but was less than the following measurements and clearance. Kaplan–Meier curves demonstrated that LC of <21.94% at T12 h and <40.3% at T24 h was associated with decreased survival (log‐rank P < 0.001). Cox proportional hazards regression analysis for mortality revealed that LC of <21.94% at T12 h had an adjusted hazard ratio (HR) of 2.73 [95% confidence interval (CI): 1.64–5.762, P < 0.001] and LC of <40.3% at T24 h had an adjusted HR of 1.98 (95% CI: 1.46–4.173, P < 0.001). The predictors of hospital mortality after PC‐ECMO were the lactate level at 12 h [odds ratio (OR): 1.67, 95% CI: 1.121–2.181, P = 0.001], initial SOFA score (OR: 1.593, 95% CI: 1.15–2.73, P < 0.001), initial blood lactate (OR: 1.21, 95% CI: 1.016–1.721, P = 0.032) and atrial fibrillation (OR: 6.17, 95% CI: 2.37–57.214, P = 0.003). Bivariate models using lactate levels and clearance at the same points revealed that blood lactate levels performed better than the clearance percentage. Conclusions Serial measurements of arterial blood lactate and LC help in obtaining early prognostic guidance in adult patients supported by VA‐ECMO after cardiac surgery. Absolute lactate levels, compared with LC at the same time points, demonstrated better performance in differentiating mortality.https://doi.org/10.1002/ehf2.14910atrial fibrillationcardiotomyextracorporeal membrane oxygenation (ECMO)lactatelactate clearancemortality
spellingShingle Mohamed Laimoud
Patricia Machado
Michelle Gretchen Lo
Mary Jane Maghirang
Emad Hakami
Rehan Qureshi
The absolute lactate levels versus clearance for prognostication of post‐cardiotomy patients on veno‐arterial ECMO
ESC Heart Failure
atrial fibrillation
cardiotomy
extracorporeal membrane oxygenation (ECMO)
lactate
lactate clearance
mortality
title The absolute lactate levels versus clearance for prognostication of post‐cardiotomy patients on veno‐arterial ECMO
title_full The absolute lactate levels versus clearance for prognostication of post‐cardiotomy patients on veno‐arterial ECMO
title_fullStr The absolute lactate levels versus clearance for prognostication of post‐cardiotomy patients on veno‐arterial ECMO
title_full_unstemmed The absolute lactate levels versus clearance for prognostication of post‐cardiotomy patients on veno‐arterial ECMO
title_short The absolute lactate levels versus clearance for prognostication of post‐cardiotomy patients on veno‐arterial ECMO
title_sort absolute lactate levels versus clearance for prognostication of post cardiotomy patients on veno arterial ecmo
topic atrial fibrillation
cardiotomy
extracorporeal membrane oxygenation (ECMO)
lactate
lactate clearance
mortality
url https://doi.org/10.1002/ehf2.14910
work_keys_str_mv AT mohamedlaimoud theabsolutelactatelevelsversusclearanceforprognosticationofpostcardiotomypatientsonvenoarterialecmo
AT patriciamachado theabsolutelactatelevelsversusclearanceforprognosticationofpostcardiotomypatientsonvenoarterialecmo
AT michellegretchenlo theabsolutelactatelevelsversusclearanceforprognosticationofpostcardiotomypatientsonvenoarterialecmo
AT maryjanemaghirang theabsolutelactatelevelsversusclearanceforprognosticationofpostcardiotomypatientsonvenoarterialecmo
AT emadhakami theabsolutelactatelevelsversusclearanceforprognosticationofpostcardiotomypatientsonvenoarterialecmo
AT rehanqureshi theabsolutelactatelevelsversusclearanceforprognosticationofpostcardiotomypatientsonvenoarterialecmo
AT mohamedlaimoud absolutelactatelevelsversusclearanceforprognosticationofpostcardiotomypatientsonvenoarterialecmo
AT patriciamachado absolutelactatelevelsversusclearanceforprognosticationofpostcardiotomypatientsonvenoarterialecmo
AT michellegretchenlo absolutelactatelevelsversusclearanceforprognosticationofpostcardiotomypatientsonvenoarterialecmo
AT maryjanemaghirang absolutelactatelevelsversusclearanceforprognosticationofpostcardiotomypatientsonvenoarterialecmo
AT emadhakami absolutelactatelevelsversusclearanceforprognosticationofpostcardiotomypatientsonvenoarterialecmo
AT rehanqureshi absolutelactatelevelsversusclearanceforprognosticationofpostcardiotomypatientsonvenoarterialecmo